ArticleJournal for immunotherapy of cancer2026

Development of an immunocompetent cutaneous squamous cell carcinoma model identifies VISTA and CTLA-4 as targetable immune checkpoints.

Alanis E Rodriguez Rosario et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.